Device type · DHA
System, Test, Human Chorionic Gonadotropin
Last checked: Nov 20, 2026Source: openFDAMethods & limitations
Product code
DHA
Clinical Chemistry
Device class
Class II
FDA decisions since 2015
13
510(k), De Novo and PMA
Adverse event reports
237
Received Nov 1, 2025 to Nov 20, 2026
How FDA classifies it
- Device type
- System, Test, Human Chorionic Gonadotropin
- Product code
- DHA
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1155
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for DHA
Latest FDA decisions
The 8 newest of 13 since 2015.
K233581 · Decided May 8, 2024 · 183 days after receipt
Device type: System, Test, Human Chorionic Gonadotropin (DHA) · Laboratory Medicine & Pathology
Shenzhen Yhlo Biotech Co., Ltd.
K223690 · Decided Dec 11, 2023 · 367 days after receipt
Device type: System, Test, Human Chorionic Gonadotropin (DHA) · Laboratory Medicine & Pathology
K230937 · Decided Jun 5, 2023 · 63 days after receipt
Device type: System, Test, Human Chorionic Gonadotropin (DHA) · Laboratory Medicine & Pathology
10 more FDA decisions with a free account
Reports received
237
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
219
92% of reports
Injury reports
18
7.6% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 19 | 1 | 0 | 0 |
| Jan 24 | 20 | 1 | 0 | 0 |
| Feb 24 | 34 | 0 | 0 | 0 |
| Mar 24 | 15 | 0 | 0 | 0 |
| Apr 24 | 22 | 0 | 0 | 0 |
| May 24 | 23 | 2 | 0 | 0 |
| Jun 24 | 16 | 0 | 0 | 0 |
| Jul 24 | 30 | 0 | 0 | 0 |
| Aug 24 | 18 | 0 | 0 | 0 |
| Sep 24 | 20 | 0 | 0 | 0 |
| Oct 24 | 19 | 0 | 0 | 0 |
| Nov 24 | 19 | 1 | 0 | 0 |
| Dec 24 | 21 | 0 | 0 | 0 |
| Jan 25 | 21 | 0 | 0 | 0 |
| Feb 25 | 17 | 0 | 0 | 0 |
| Mar 25 | 18 | 0 | 0 | 0 |
| Apr 25 | 27 | 0 | 0 | 0 |
| May 25 | 19 | 0 | 0 | 0 |
| Jun 25 | 22 | 0 | 0 | 0 |
| Jul 25 | 17 | 0 | 0 | 0 |
| Aug 25 | 18 | 1 | 0 | 0 |
| Sep 25 | 15 | 0 | 0 | 0 |
| Oct 25 | 24 | 0 | 0 | 0 |
| Nov 25 | 15 | 2 | 0 | 0 |
| Dec 25 | 21 | 1 | 0 | 0 |
| Jan 26 | 13 | 0 | 0 | 0 |
| Feb 26 | 15 | 9 | 0 | 0 |
| Mar 26 | 26 | 0 | 0 | 0 |
| Apr 26 | 12 | 0 | 0 | 0 |
| May 26 | 18 | 0 | 0 | 0 |
| Jun 26 | 16 | 1 | 0 | 0 |
| Jul 26 | 14 | 3 | 0 | 0 |
| Aug 26 | 17 | 2 | 0 | 0 |
| Sep 26 | 13 | 0 | 0 | 0 |
| Oct 26 | 39 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Abbott121
3 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- False Positive Result108
- High Test Results55
- Non Reproducible Results54
7 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions215
- Insufficient Information12
- Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available9
1 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Alinity Reaction Vessels, REF: 06P1401, for use with Alinity i Systems; ARCHITECT Reaction VesselsOpen, Classified
Z-0958-2023 · Started Nov 24, 2022 · Posted by FDA Jan 17, 2023
Reason given: Reaction vessels may contain a potential contaminant that could affect their optical performance.
Cause as FDA categorized it: Material/Component Contamination
Siemens Healthcare Diagnostics, Inc.
Z-1015-2022 · Started Feb 22, 2022
Reason given: Potential for falsely elevated hCG results due to sample carryover in serum and urine patient samples, as well as quality control samples and adjustors.
Cause as FDA categorized it: Under Investigation by firm
Abbott Ireland Diagnostics Division
Z-0666-2019 · Started Nov 21, 2018
Reason given: Abbott has become aware of a manufacturing issue that can result in damage to a bottle neck in some of the reagent cartridges found in the lots listed in Appendix A. If a bottle neck is damaged, it may cause a failure during the reagent loading process on the Alinity i instrument.
Cause as FDA categorized it: Nonconforming Material/Component
11 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.